
Dr.Monica Avila
@mavilamd
Gynecologic Oncologist @Moffittnews. Targeted Therapy Explorer. Trained @MDAndersonnews #gyncsm. Views are mine alone.
ID: 1107482986818105345
18-03-2019 03:24:54
309 Tweet
994 Followers
782 Following

Tomorrow at #SGOMtg, join Moffitt's Erin George, MD (Erin George) as she explores the impact of CCNE1 gene changes on cancer behavior and patient outcomes in high-grade serous ovarian and endometrial cancer. Don't miss this important discussion on how genetic insights can guide


LIVE from #SGOMtg, Moffitt's Erin George, MD (Erin George) shares the impact of CCNE1 gene changes on cancer behavior and patient outcomes in high-grade serous ovarian and endometrial cancer. #MoffittSGO25 Key findings: • CCNE1 amplification rates in HGSOC and EMCA depend on



.Moffitt Cancer Center has been recognized with the 2024 Press Ganey Human Experience (HX) Pinnacle of Excellence and Guardian of Excellence Awards, reinforcing its commitment to exceptional patient care. centralfloridahealthnews.com/moffitt-cancer…


What is groundbreaking CAR-T cell therapy in ovarian cancer? Here to tell us, is Dr. Monica Avila at #ZealForTeal2025! 👏 Moffitt Cancer Center




It's fellowship season!!! Come join Moffitt Cancer Center as a fellow MoffittGYNONC with our multidisciplinary approach to cancer, state of the art surgical hospital, surgical labs, unmatched volume and advances in cellular therapy!!! Jeannie Chern Robert Wenham Karen Lu Dr. Patrick Hwu


The one and only Ben Creelan, MD from Moffitt Cancer Center giving us the rapid rundown on all #lungcancer cell therapy targets at iwCAR-T! #TIL #TCR #CART


Our incredible Mihaela Druta presenting her FDA Oncology approved AFAMI-CEL, the first #TCR in solid tumors at iwCAR-T Moffitt Cancer Center!


Excited to share our work and #superresponder with the FSH #CART therapy trial only MoffittGYNONC Moffitt Cancer Center with Robert Wenham and Jose Conejo-Garcia at iwCAR-T!!


Proud to be a Scientific Board member and to lead the use of a novel drug harnessing powerful yet safe cytokines. #FirstResponse in #ovariancancer Moffitt Cancer Center MoffittGYNONC SGO onclive.com/view/son-1010-…


Erin George, MD (Erin George) shares her #AACR25 abstract on 3D modeling of ovarian cancer. In collaboration with Moffitt’s bioengineering team, an in vitro system was developed to preserve tumor complexity, improve response prediction, and pave the way for more personalized

Congrats team! Check out our collab MCC Department of Anesthesiology and Critical Care & MoffittGYNONC. #CancerControl paper noting intraop blood tx & length of stay (>3d) associated with ⬇️ survival in surgical debulking for #OvarianCancer Moffitt Cancer Center Robert Wenham #multidsciplinaryscience journals.sagepub.com/doi/10.1177/10…

New large observational study from #ASCO25 shows the ⬇️ in cancer incidence and all cause mortality. Moffitt Cancer Center MoffittGYNONC we're exploring how these drugs are playing a role in secondary and tertiary prevention of #gyn cancers!

#GLP1 agonists are ⬇️ cancers linked to obesity #ASCO25. By inadvertently ⬇️ appetite and modifying diet, they're also modifying rates of cancers associated with variations in diet. MoffittGYNONC we're seeing if using them after cancer treatment also helps.

From #ASCO25: Amalia Stefanou, MD (Amalia Stefanou MD) shares how an APP-first care model boosted access for GI cancer patients and streamlined their path to treatment. #MoffittASCO25
